About: Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.62 (+4.08%)
APRE NASDAQ Aprea Therapeutics Inc
Aprea Therapeutics Inc share price
APRE price activity
Last Price
$0.620
Change (24hr)
0.02 USD (4.08%)
Volume
98.91K
Volume (4w avg)
-
Open
$0.61
Day Range
$0.61 - $0.62
Previous Close
$0.59
Last Trade
13 Oct, 5:25 pm GMT+0
Delayed
13 Oct, 5:25 pm GMT+0
APRE price performance
Delayed
13 Oct, 5:25 pm GMT+0
APRE Market Signals